tirzepatide weight loss per month average outperformed semaglutide weight-loss drug results in real world patients, study shows How Fast Can You Lose

Retatrutide shows potential for greater efficacy through triple-agonism but awaits Phase 3 results Best For Recommendations# Currently Available Treatment# Recommendation : Tirzepatide Reason : FDA-approved and commercially available as Mounjaro/Zepbound with established dosing protocols and post-market safety data Maximum Weight Loss Potential# Recommendation : Retatrutide Reason : Phase 2 data showed 24.2% weight loss at 48 weeks, exceeding tirzepatide's results, though Phase 3 confirmation is pending Non-Alcoholic Fatty Liver Disease# Recommendation : Retatrutide Reason : Glucagon receptor agonism directly promotes hepatic fat oxidation, showing up to 82% liver fat reduction in trials Type 2 Diabetes Management# Recommendation : Tirzepatide Reason : Proven HbA1c reduction with FDA approval specifically for glycemic control in type 2 diabetes Further Reading# Which Is Better For

Hustad S, McKinley MC, McNulty H, Schneede J, Strain JJ, Scott JM, Ueland PM

Weight Management (Obesity and Overweight) This option is typically prescribed for: 3

HFpEF is strongly linked to obesity, as over 80% of HFpEF patients are overweight or obese